No Data
Fulcrum Therapeutics to Present at the 31st Annual FSHD Society International Research Congress
CAMBRIDGE, Mass., June 12, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (the "Company") (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to imp
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Fulcrum Therapeutics to Participate in the Goldman Sachs' 45th Annual Global Healthcare Conference
CAMBRIDGE, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (the "Company") (NASDAQ:FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives
Goldman Sachs Predicts up to 108% Rally for These 2 'Strong Buy' Stocks
Fulcrum Therapeutics (NASDAQ:FULC) Readies Phase 3 Candidate With Blockbuster Potential
Fulcrum Therapeutics Initiated at Overweight by Cantor Fitzgerald
Fulcrum Therapeutics Initiated at Overweight by Cantor Fitzgerald
JESSE JAMES8832 : might be something
TrytosaveabitOP JESSE JAMES8832: Yup! I will be looking to see where it starts to consolidate over the next couple weeks. Then start scaling in!